Gut permeability, circulating bacterial fragments and measures of congestion in peritoneal dialysis
© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA..
Background: Limited data exist on the association between gut permeability, circulating bacterial fragment and volume overload in peritoneal dialysis (PD) patients. We measured circulating bacterial fragments, N-terminal pro B-type natriuretic peptide (NT-proBNP), calprotectin and zonulin levels, and evaluate their association with the clinical outcomes in PD patients.
Methods: This was a single-center prospective study on 108 consecutive incident PD patients. Plasma endotoxin and bacterial DNA, and serum NT-proBNP, calprotectin and zonulin levels were measured. Primary outcomes were technique and patient survival, secondary outcomes were hospitalization data.
Results: There was no significant correlation between plasma endotoxin and bacterial DNA, and serum NT-proBNP, calprotectin and zonulin levels. The Homeostatic Model Assessment for Insulin Resistance (HOMA)-2β index, which represents insulin resistance, positively correlated with plasma bacterial DNA (r = 0.421, P < .001) and calprotectin levels (r = 0.362, P = .003), while serum NT-proBNP level correlated with the severity of volume overload and residual renal function. Serum NT-proBNP level was associated with technique survival even after adjusting for confounding factors [adjusted hazard ratio (aHR) 1.030, 95% confidence interval 1.009-1.051]. NT-proBNP level was also associated with patient survival by univariate analysis, but the association became insignificant after adjusting for confounding factors (aHR 1.010, P = .073). Similarly, NT-proBNP correlated with the number of hospitalizations and duration of hospitalization by univariate analysis, but the association became insignificant after adjusting for confounding factors.
Conclusion: There was no correlation between markers of gut permeability, circulating bacterial fragments and measures of congestion in PD patients. Bacterial fragments levels and gut permeability are both associated with insulin resistance. Serum NT-proBNP level is associated with the severity of volume overload and technique survival. Further studies are required to delineate the mechanism of high circulating bacterial fragment levels in PD patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Clinical kidney journal - 17(2024), 3 vom: 03. März, Seite sfae056 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Chuanlei [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 23.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1093/ckj/sfae056 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370060962 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM370060962 | ||
003 | DE-627 | ||
005 | 20240323235841.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240323s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/ckj/sfae056 |2 doi | |
028 | 5 | 2 | |a pubmed24n1343.xml |
035 | |a (DE-627)NLM370060962 | ||
035 | |a (NLM)38516523 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Chuanlei |e verfasserin |4 aut | |
245 | 1 | 0 | |a Gut permeability, circulating bacterial fragments and measures of congestion in peritoneal dialysis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 23.03.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © The Author(s) 2024. Published by Oxford University Press on behalf of the ERA. | ||
520 | |a Background: Limited data exist on the association between gut permeability, circulating bacterial fragment and volume overload in peritoneal dialysis (PD) patients. We measured circulating bacterial fragments, N-terminal pro B-type natriuretic peptide (NT-proBNP), calprotectin and zonulin levels, and evaluate their association with the clinical outcomes in PD patients | ||
520 | |a Methods: This was a single-center prospective study on 108 consecutive incident PD patients. Plasma endotoxin and bacterial DNA, and serum NT-proBNP, calprotectin and zonulin levels were measured. Primary outcomes were technique and patient survival, secondary outcomes were hospitalization data | ||
520 | |a Results: There was no significant correlation between plasma endotoxin and bacterial DNA, and serum NT-proBNP, calprotectin and zonulin levels. The Homeostatic Model Assessment for Insulin Resistance (HOMA)-2β index, which represents insulin resistance, positively correlated with plasma bacterial DNA (r = 0.421, P < .001) and calprotectin levels (r = 0.362, P = .003), while serum NT-proBNP level correlated with the severity of volume overload and residual renal function. Serum NT-proBNP level was associated with technique survival even after adjusting for confounding factors [adjusted hazard ratio (aHR) 1.030, 95% confidence interval 1.009-1.051]. NT-proBNP level was also associated with patient survival by univariate analysis, but the association became insignificant after adjusting for confounding factors (aHR 1.010, P = .073). Similarly, NT-proBNP correlated with the number of hospitalizations and duration of hospitalization by univariate analysis, but the association became insignificant after adjusting for confounding factors | ||
520 | |a Conclusion: There was no correlation between markers of gut permeability, circulating bacterial fragments and measures of congestion in PD patients. Bacterial fragments levels and gut permeability are both associated with insulin resistance. Serum NT-proBNP level is associated with the severity of volume overload and technique survival. Further studies are required to delineate the mechanism of high circulating bacterial fragment levels in PD patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a cardiovascular disease | |
650 | 4 | |a inflammation | |
650 | 4 | |a metabolism | |
700 | 1 | |a Ng, Jack Kit-Chung |e verfasserin |4 aut | |
700 | 1 | |a Chan, Gordon Chun-Kau |e verfasserin |4 aut | |
700 | 1 | |a Fung, Winston Wing-Shing |e verfasserin |4 aut | |
700 | 1 | |a Lai, Ka-Bik |e verfasserin |4 aut | |
700 | 1 | |a Poon, Peter Yam-Kau |e verfasserin |4 aut | |
700 | 1 | |a Luk, Cathy Choi-Wan |e verfasserin |4 aut | |
700 | 1 | |a Chow, Kai-Ming |e verfasserin |4 aut | |
700 | 1 | |a Szeto, Cheuk-Chun |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical kidney journal |d 2012 |g 17(2024), 3 vom: 03. März, Seite sfae056 |w (DE-627)NLM219739579 |x 2048-8505 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2024 |g number:3 |g day:03 |g month:03 |g pages:sfae056 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/ckj/sfae056 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2024 |e 3 |b 03 |c 03 |h sfae056 |